Related Experiment Video

Updated: Aug 18, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Cardiovascular effects of aldosterone

J Murin1

  • 11st Department of Internal Medicine, Faculty of Medicine, Comenius University, University Hospital, Bratislava, Slovakia. murin@faneba.sk

Bratislavske Lekarske Listy
|May 5, 2005
PubMed

Insights

Aldosterone significantly impacts body fluid balance and directly contributes to cardiovascular diseases like hypertension and heart failure. Understanding its role is crucial for managing these conditions.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Aldosterone is a key hormone regulating sodium/potassium and water balance.
  • Emerging evidence highlights aldosterone's detrimental role in cardiovascular pathophysiology.
  • Direct effects of aldosterone on vasculature and cardiac tissue are increasingly recognized.

Purpose of the Study:

  • To provide a comprehensive overview of aldosterone's role.
  • To elucidate the pathophysiology of aldosterone-related cardiovascular diseases.
  • To discuss the implications of aldosterone in hypertension and heart failure.

Main Methods:

  • Literature review and synthesis of current research.
  • Analysis of aldosterone's direct effects on cardiovascular and renal systems.
  • Integration of data on aldosterone's contribution to disease development.

Main Results:

  • Aldosterone is central to fluid homeostasis.
  • Aldosterone directly promotes cardiovascular pathologies including hypertension, left ventricular hypertrophy, heart failure, and renal failure.
  • The hormone's detrimental effects extend to blood vessels and the heart.

Conclusions:

  • Aldosterone is a critical factor in cardiovascular and renal disease.
  • Targeting aldosterone pathways may offer therapeutic benefits for conditions like hypertension and heart failure.
  • Further research into aldosterone's mechanisms is warranted for improved patient outcomes.

More Related Videos

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...